Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
University of Alberta
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
Nanjing First Hospital, Nanjing Medical University
British Columbia Cancer Agency
Instituto do Cancer do Estado de São Paulo
Children's Hospitals and Clinics of Minnesota
University of Texas Southwestern Medical Center
Northwell Health
Peking Union Medical College Hospital
Children's Hospital Medical Center, Cincinnati
University of Iowa
University of Alberta
University of Iowa
British Columbia Cancer Agency
University of Iowa
University of California, San Francisco
Stanford University
University of Iowa
University of Iowa
M.D. Anderson Cancer Center
Children's Hospital Medical Center, Cincinnati